Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
Key facts
- Who runs it
- Second Affiliated Hospital of Wenzhou Medical University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 100 people, planned
- Started
- 1 Jan 2019
- Planned end
- 30 Dec 2025
- Type of study
- Observational
- Record updated
- 1 April 2025
Who can take part
- Age
- 18 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Temperature > 38°C or < 36°C
- Heart rate > 90 beats/min
- Respiratory rate > 20 breaths/min or PaCO₂ < 32 mmHg
- White blood cell count > 12.0 × 10⁹/L or < 4.0 × 10⁹/L, or > 10% immature neutrophils
- Initial septic shock diagnosis
- Organ dysfunction (cardiovascular, respiratory, or ≥ 2 other organs)
- Complete clinical data
Who cannot take part
- Chemotherapy
- Radiotherapy
- Cancer history
- Controls were free of infectious or inflammatory diseases and glucocorticoid use
- Incomplete data
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The condition of sepsis patients changes rapidly, whom are often accompanied by impaired respiratory, circulatory, renal, and coagulation functions. So far, the prognosis of sepsis at home and abroad is not ideal. Participants was randomly included in this research project on the pathogenesis and prevention of sepsis due to typical sepsis symptoms. the investigators will collect appropriate clinical specimens for analysis of immune cell functions and pathogenic microorganisms combined with individual patient research. This study will enable sepsis patients to be identified early and receive earlier anti-sepsis treatment, which is expected to improve the prognosis of sepsis, shorten hospitalization time, and reduce treatment costs.
Read full original descriptionShow less
The above-mentioned tests and analyses do not increase the economic burden on the participants, and the required expenses are all paid from the project funds; they do not affect the prognosis and rehabilitation process of participants, and do not have adverse effects on the health of participants.
The group in the trial
- sepsis and control
The presence of sepsis at the time of admission to the ICU is called sepsis, and the absence of sepsis is called control.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT06904001, who can take part
- Record updated
- 1 April 2025